was an estrogen touchy cancer and that testosterone acted as a counter balance to estrogen. Clinical trials in primates and human beings have showed that testosterone has a beneficial impact on breast tissue through lowering breast proliferation and preventing stimulation from estradiol. But, some epidemiological studies have stated an association among improved androgens and breast cancer. However those studies suffer from methodological limitations, and extra importantly, do not account for related Titanodrol expanded estradiol stages and expanded frame mass index. And the cause and effect interpretation of those studies conflicts with the recognized biological effect of testosterone. Although testosterone is breast defensive, it may aromatize to estradiol and have a secondary, stimulatory effect on the estrogen receptor. However when testosterone is combined with an aromatase inhibitor in a subcutaneous implant, it blocks testosterone from aromatizing. This form of remedy has been shown to successfully.